Pharmacy Technician Midterm | 191 Questions
and Correct Answers plus Rationale | New
Update 2026-2027 | Already Graded A+
PHARMACY LAW AND ACTS
Question 1
PharmD stands for:
A. Doctor of Pharmacy
B. Doctor of Pharmacology
C. Doctor of Pharmaceutical Sciences
D. Doctor of Pharmacotherapy
Correct Answer: A. Doctor of Pharmacy
Rationale: PharmD stands for Doctor of Pharmacy, which is the professional
doctoral degree required to become a licensed pharmacist in the United States. It
is a clinical degree that replaced the Bachelor of Science in Pharmacy (BSPharm)
as the entry-level degree for pharmacy practice.
Question 2
This act was designed to increase safeguards to prevent the introduction and
retail sale of substandard, ineffective, and counterfeit drugs in the U.S. supply
chain.
A. Prescription Drug Marketing Act
B. Omnibus Budget Reconciliation Act
C. Drug Listing Act
D. Orphan Drug Act
Correct Answer: A. Prescription Drug Marketing Act
,Rationale: The Prescription Drug Marketing Act (PDMA) was enacted to prevent
the introduction and retail sale of substandard, ineffective, and counterfeit drugs
in the U.S. supply chain. It regulates the distribution of drug samples and prohibits
the re-importation of prescription drugs manufactured in the U.S.
Question 3
This act requires that pharmacies that fill prescriptions for Medicaid obtain,
record, and maintain basic patient information.
A. Prescription Drug Marketing Act
B. Omnibus Budget Reconciliation Act (OBRA)
C. Drug Listing Act
D. Health Insurance Portability and Accountability Act
Correct Answer: B. Omnibus Budget Reconciliation Act (OBRA)
Rationale: The Omnibus Budget Reconciliation Act (OBRA) of 1990 requires that
pharmacies filling prescriptions for Medicaid patients obtain, record, and maintain
basic patient information. It also mandates prospective drug utilization review
(DUR) and patient counseling for Medicaid patients. OBRA established the
standard of care for pharmacy practice.
Question 4
The mixing of herbs and chemicals to create tablets, capsules, ointments, and
solutions is called:
A. Compounding
B. Manufacturing
C. Formulation
D. Synthesis
Correct Answer: A. Compounding
Rationale: Compounding is the mixing of ingredients (herbs, chemicals, active
pharmaceutical ingredients) to create customized medications for individual
patients. It differs from manufacturing, which is large-scale production of
,standardized drugs. Compounding is done in pharmacies, while manufacturing is
done by pharmaceutical companies.
Question 5
Also known as the Drug Price Competition and Patent-Term Restoration Act, this
act ensured that brand-name drug manufacturers would have patent protection
and a period of marketing exclusivity to enable them to recoup their
investments in the development of valuable new drugs, as well as provide an
incentive for new drugs to reach the marketplace.
A. Waxman-Hatch Act
B. Orphan Drug Act
C. FDA Modernization Act
D. Durham-Humphrey Amendment
Correct Answer: A. Waxman-Hatch Act
Rationale: The Waxman-Hatch Act (Drug Price Competition and Patent-Term
Restoration Act) of 1984 provides patent protection and marketing exclusivity for
brand-name drug manufacturers. It also created the Abbreviated New Drug
Application (ANDA) process for generic drugs, balancing innovation incentives
with access to affordable medications.
Question 6
This was enacted to stimulate the development of drugs for rare diseases.
A. Waxman-Hatch Act
B. Orphan Drug Act
C. FDA Modernization Act
D. Food and Drug Administration Act
Correct Answer: B. Orphan Drug Act
Rationale: The Orphan Drug Act of 1983 was enacted to encourage the
development of drugs for rare diseases (affecting fewer than 200,000 people in
the U.S.). It provides tax incentives, grants, and marketing exclusivity to
, pharmaceutical companies that develop orphan drugs. Examples include drugs for
Huntington's disease, ALS, and certain rare cancers.
Question 7
This act was implemented to improve continuity and portability when
transferring health-insurance coverage from one employer to another.
A. Health Insurance Portability and Accountability Act (HIPAA)
B. Omnibus Budget Reconciliation Act (OBRA)
C. Medicare Prescription Drug Act
D. Food and Drug Administration Act
Correct Answer: A. Health Insurance Portability and Accountability Act (HIPAA)
Rationale: HIPAA (Health Insurance Portability and Accountability Act) was
implemented in 1996 to improve continuity and portability when transferring
health insurance coverage from one employer to another. It also establishes
national standards for electronic healthcare transactions and protects the privacy
and security of patients' Protected Health Information (PHI).
Question 8
This act gives all people who receive Medicare benefits the option for
prescription-drug coverage under the Medicare Part D plan.
A. Medicare Prescription Drug, Improvement, and Modernization Act
B. Omnibus Budget Reconciliation Act
C. Health Insurance Portability and Accountability Act
D. Food and Drug Administration Act
Correct Answer: A. Medicare Prescription Drug, Improvement, and
Modernization Act
Rationale: The Medicare Prescription Drug, Improvement, and Modernization
Act of 2003 (also called the Medicare Modernization Act) created Medicare Part
D, which provides prescription drug coverage for Medicare beneficiaries. It is the
largest expansion of Medicare since its inception in 1965.
and Correct Answers plus Rationale | New
Update 2026-2027 | Already Graded A+
PHARMACY LAW AND ACTS
Question 1
PharmD stands for:
A. Doctor of Pharmacy
B. Doctor of Pharmacology
C. Doctor of Pharmaceutical Sciences
D. Doctor of Pharmacotherapy
Correct Answer: A. Doctor of Pharmacy
Rationale: PharmD stands for Doctor of Pharmacy, which is the professional
doctoral degree required to become a licensed pharmacist in the United States. It
is a clinical degree that replaced the Bachelor of Science in Pharmacy (BSPharm)
as the entry-level degree for pharmacy practice.
Question 2
This act was designed to increase safeguards to prevent the introduction and
retail sale of substandard, ineffective, and counterfeit drugs in the U.S. supply
chain.
A. Prescription Drug Marketing Act
B. Omnibus Budget Reconciliation Act
C. Drug Listing Act
D. Orphan Drug Act
Correct Answer: A. Prescription Drug Marketing Act
,Rationale: The Prescription Drug Marketing Act (PDMA) was enacted to prevent
the introduction and retail sale of substandard, ineffective, and counterfeit drugs
in the U.S. supply chain. It regulates the distribution of drug samples and prohibits
the re-importation of prescription drugs manufactured in the U.S.
Question 3
This act requires that pharmacies that fill prescriptions for Medicaid obtain,
record, and maintain basic patient information.
A. Prescription Drug Marketing Act
B. Omnibus Budget Reconciliation Act (OBRA)
C. Drug Listing Act
D. Health Insurance Portability and Accountability Act
Correct Answer: B. Omnibus Budget Reconciliation Act (OBRA)
Rationale: The Omnibus Budget Reconciliation Act (OBRA) of 1990 requires that
pharmacies filling prescriptions for Medicaid patients obtain, record, and maintain
basic patient information. It also mandates prospective drug utilization review
(DUR) and patient counseling for Medicaid patients. OBRA established the
standard of care for pharmacy practice.
Question 4
The mixing of herbs and chemicals to create tablets, capsules, ointments, and
solutions is called:
A. Compounding
B. Manufacturing
C. Formulation
D. Synthesis
Correct Answer: A. Compounding
Rationale: Compounding is the mixing of ingredients (herbs, chemicals, active
pharmaceutical ingredients) to create customized medications for individual
patients. It differs from manufacturing, which is large-scale production of
,standardized drugs. Compounding is done in pharmacies, while manufacturing is
done by pharmaceutical companies.
Question 5
Also known as the Drug Price Competition and Patent-Term Restoration Act, this
act ensured that brand-name drug manufacturers would have patent protection
and a period of marketing exclusivity to enable them to recoup their
investments in the development of valuable new drugs, as well as provide an
incentive for new drugs to reach the marketplace.
A. Waxman-Hatch Act
B. Orphan Drug Act
C. FDA Modernization Act
D. Durham-Humphrey Amendment
Correct Answer: A. Waxman-Hatch Act
Rationale: The Waxman-Hatch Act (Drug Price Competition and Patent-Term
Restoration Act) of 1984 provides patent protection and marketing exclusivity for
brand-name drug manufacturers. It also created the Abbreviated New Drug
Application (ANDA) process for generic drugs, balancing innovation incentives
with access to affordable medications.
Question 6
This was enacted to stimulate the development of drugs for rare diseases.
A. Waxman-Hatch Act
B. Orphan Drug Act
C. FDA Modernization Act
D. Food and Drug Administration Act
Correct Answer: B. Orphan Drug Act
Rationale: The Orphan Drug Act of 1983 was enacted to encourage the
development of drugs for rare diseases (affecting fewer than 200,000 people in
the U.S.). It provides tax incentives, grants, and marketing exclusivity to
, pharmaceutical companies that develop orphan drugs. Examples include drugs for
Huntington's disease, ALS, and certain rare cancers.
Question 7
This act was implemented to improve continuity and portability when
transferring health-insurance coverage from one employer to another.
A. Health Insurance Portability and Accountability Act (HIPAA)
B. Omnibus Budget Reconciliation Act (OBRA)
C. Medicare Prescription Drug Act
D. Food and Drug Administration Act
Correct Answer: A. Health Insurance Portability and Accountability Act (HIPAA)
Rationale: HIPAA (Health Insurance Portability and Accountability Act) was
implemented in 1996 to improve continuity and portability when transferring
health insurance coverage from one employer to another. It also establishes
national standards for electronic healthcare transactions and protects the privacy
and security of patients' Protected Health Information (PHI).
Question 8
This act gives all people who receive Medicare benefits the option for
prescription-drug coverage under the Medicare Part D plan.
A. Medicare Prescription Drug, Improvement, and Modernization Act
B. Omnibus Budget Reconciliation Act
C. Health Insurance Portability and Accountability Act
D. Food and Drug Administration Act
Correct Answer: A. Medicare Prescription Drug, Improvement, and
Modernization Act
Rationale: The Medicare Prescription Drug, Improvement, and Modernization
Act of 2003 (also called the Medicare Modernization Act) created Medicare Part
D, which provides prescription drug coverage for Medicare beneficiaries. It is the
largest expansion of Medicare since its inception in 1965.